In its latest report, BCC Research projects the global drug delivery market to grow to nearly $227.3 billion by 2020, with a compound annual growth rate of 4.9 percent. This is great news for the French company Nemera, which designs and manufactures world-class drug delivery devices for the pharmaceutical industry.
Founded in the early 1960s as Rexam Healthcare, Nemera currently operates manufacturing plants in La Verpillière and Le Tréport, France; Neuenburg, Germany; and Buffalo Grove, IL, in the United States. Only the Neuenburg location produces devices made of injection-molded thermoplastic. These products are assembled on rotary and linear high-speed lines using robots and ultrasonic welding, before being packed with automated equipment.